← brief for 2026-10-07 · Slowing decline

EHA Guidelines on the management of children and adults with hemoglobin SC disease

Article No results yet Peer reviewed

Key takeaways

Who did this work

Rees D (School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London) · Brousse V (Hôpital Universitaire Robert Debré, APHP) · de Montalembert M (Université Paris‐Cité; INSERM, EFS, BIGR U1134) · Biemond B (Amsterdam University Medical Center, University of Amsterdam) · De Franceschi L (Azienda Ospedaliera Universitaria Integrate, Verona) · Oteng‐Ntim E (School of Lifecourse Sciences, FoLSM, King's College London) · Flevari P (Hemoglobinopathies Expertise Center‐Member of EuroBloodNet) · Pinto V (IRCCS Azienda Ospedaliera Metropolitana Ospedale Policlinico San Martino) · James J (Sickle Cell Society) · Cela E (Hospital General Universitario Gregorio Marañón. ERN‐EuroBloodNet, Universidad Complutense de Madrid) · Eber S (Special Praxis for Paediatric Haematology/Haemostaseology, Childrens Hospital Technical University) · Kesse‐Adu R (Guy's and St Thomas NHS Foundation Trust)

Source

Article · Europe PMC, CKD · 2026-10-01
https://europepmc.org/article/PMC/PMC13641183